Oncology-Chemotherapeutic Dose Intensification in Oncology

Oncology-Chemotherapeutic Dose Intensification in Oncology This guide summarizes the provided text on dose intensification in cancer treatment, focusing on key concepts and clinical applications. I. Dose-Response and Dose Intensification: • Central Ide


Oncology- Drug Resistance in Oncology

Oncology- Drug Resistance in Oncology This study guide summarizes the provided text on drug resistance in cancer treatment. Understanding these mechanisms is crucial for developing effective therapies. I. Introduction: The Problem of Drug Resistance •


Oncology- The Role of Unsealed Radionuclides in Oncology

Oncology- The Role of Unsealed Radionuclides in Oncology ## I. Nuclear Medicine in Oncology: The Big Picture Nuclear medicine uses radioactive substances (radionuclides) to: * **Localize tumors:** Pinpoint the location of a cancerous growth. * **Det


Pathology-Intraoperative Radiotherapy (IORT)

Pathology-Intraoperative Radiotherapy (IORT) **I. Definition and Principle:** Intraoperative radiotherapy (IORT) delivers a single, high dose of external beam radiotherapy (EBRT) directly to exposed diseased tissue during surgery. This targeted approac


Oncology-Anti-Microtubule Agents

Oncology-Anti-Microtubule Agents I. Core Concept: Anti-microtubule agents, also known as "spindle poisons," are a class of cancer drugs that target tubulin, a protein forming microtubules crucial for cell division. By disrupting microtubule function, th


Oncology-Topoisomerase Inhibitors

Oncology-Topoisomerase Inhibitors I. Topoisomerases: The Basics • Function: Topoisomerases are nuclear proteins crucial for managing DNA topology (shape and structure). They regulate DNA supercoiling, a process essential for replication, transcription,


Oncology-Chemotherapy: Cisplatin and its Analogues

Oncology-Chemotherapy: Cisplatin and its Analogues - I. Cisplatin A. Mechanism of Action: • Cisplatin directly binds to DNA, forming intra-strand and inter-strand cross-links. • This inhibits DNA synthesis by altering the DNA template. It acts as a bi


Oncology-Anti-Metabolites

Oncology-Anti-Metabolites I. Introduction to Anti-Metabolites • Mechanism: Anti-metabolites disrupt normal nucleic acid metabolism, primarily during the S-phase of the cell cycle (Fig 5.1). They are widely used cytotoxic agents, not limited to cancer tr


Oncology-Anti-Tumor Antibiotics

Oncology-Anti-Tumor Antibiotics I. Anthracyclines (Doxorubicin, Daunorubicin, Epirubicin, Idarubicin) A. Mechanism of Action: • Multiple Effects: Anthracyclines affect cell surfaces, signal transduction (activating protein kinase C), and, most importan


Oncology-Alkylating Agents

Oncology-Alkylating Agents I. Introduction Alkylating agents are antiproliferative cytotoxic drugs used in cancer chemotherapy. They function by covalently binding to DNA via alkyl groups, primarily causing cross-linking. This leads to cell cycle arrest